Page 178 - 《精细化工》2020年第11期

·2324· 精细化工 FINE CHEMICALS 第 37 卷

此外，为了评价化合物Ⅳ的生物安全性，测试 [3] PETER S, ADERIBIGBE B A. Ferrocene-based compounds with
antimalaria/anticancer activity[J]. Molecules, 2019, 24(19): 3604.
了其对正常的乳腺上皮细胞 MCF-10A 的抑制活性。 [4] KEALY T J, PAUSON P L. A new type of organo-iron compound[J].
表 3 的结果表明，化合物Ⅳ对正常的 MCF-10A 没有 Nature, 1951, 168(4285): 1039-1040.
[5] MUKHOPADHYAY A, BERNARD B, LIU K X, et al. Molecular
毒性（IC 50 > 100 μmol/L），而阳性对照药物 5-FU 却 strategies to modulate the electrochemical properties of P-type Si
展现出了一定的毒性〔IC 50 = (14.3  2.19) μmol/L〕； (111) surfaces covalently functionalized with ferrocene and naphthalene
diimide[J]. Journal of Physical Chemistry B, 2019, 123(51): 11026-11041.
同时，化合物Ⅳ的体外治疗指数〔ITVI > 7.7，其中， [6] MORRIS L J, WHITTELL G R, ELOI J C, et al. Ferrocene-containing
IVTI = IC 50 (MCF-10A)/IC 50 (MDA-MB-231) 〕也高 polycarbosilazanes via the alkaline-earth-catalyzed dehydrocoupling
of silanes and amines[J]. Organometallics, 2019, 38(19): 3629-3648.
于 5-FU（ITVI = 1.5），IVTI 值越高 [20] ，化合物的安 [7] LAI Y Y, LI X, ZHU Y. Polymeric active materials for redox flow
battery application[J]. ACS Applied Polymer Materials, 2020, 2(2):
全性也就越高。 113-128.
[8] WANG R, CHEN H H, YAN W T, et al. Ferrocene-containing
表 3 化合物Ⅳ的抗肿瘤活性（n = 3） hybrids as potential anticancer agents: Current developments,
Table 3 Anti-proliferative activity of compound Ⅳ(n = 3) mechanisms of action and structure-activity relationships[J].
European Journal of Medicinal Chemistry, 2020, 190: 112109.
IC 50/(μmol/L) [9] XIAO J Q, SUN Z, KONG F G, et al. Current scenario of
细胞种类
Ⅳ 5 - F U ferrocene-containing hybrids for antimalarial activity[J]. European
Journal of Medicinal Chemistry, 2020, 185: 111791.
MCF-7 17.4  1.86 11.7  2.04 [10] HU Q, GAN S Y, BAO Y, et al. Controlled/“living” radical
MDA-MB-231 12.9  2.09 9.1  0.96 polymerization-based signal amplification strategies for biosensing[J].
Journal of Materials Chemistry B, 2020, 8(16): 3327-3340.
Hep G2 20.7  3.64 12.4  1.53 [11] PIOTROWICZ M, KOWALCZYK A, TRZYBINŃSKI D, et al.
HeLa 24.6  2.25 9.8  1.04 Redox-active glycol nucleic acid (GNA) components: Synthesis and
properties of the ferrocenyl-GNA nucleoside, phosphoramidite, and
MCF-10A >100 14.3  2.19
semicanonical dinucleoside phosphate[J]. Organometallics, 2020, 39(6):

813-823.
3 结论 [12] SKOUPILOVA H, BARTOSIK M, SOMMEROVA L, et al. Ferrocenes
as new anticancer drug candidates: Determination of the mechanism
of action[J]. European Journal of Pharmacology, 2020, 867: 172825.
作者以二茂铁为原料，通过 Willgerodt-Kindler [13] CHEN Y, YAO Y C, ZHUO X Y, et al. Cascade-reaction-based
nanodrug for combined chemo/starvation/chemodynamic therapy against
反应制备出二茂铁基乙酸，再通过还原反应制得了
multidrug-resistant tumors[J]. ACS Applied Materials & Interfaces,
化合物Ⅳ。通过对二茂铁基乙酸还原的工艺条件优 2019, 11(49): 46112-46123.
[14] TOP S, VESSIÈRES A, LECLERCQ G, et al. Synthesis, biochemical
化，确定了适宜反应条件为：还原剂为 LiAlH 4 ，用
properties and molecular modelling studies of organometallic
量为 n(LiAlH 4 )∶n(二茂铁基乙酸)= 8∶1；四氢呋喃 specific estrogen receptor modulators (SERMs), the ferrocifens and
hydroxyferrocifens: Evidence for an antiproliferative effect of
为溶剂；反应温度 25 ℃；反应时间 24 h。在该条 hydroxyferrocifens on both hormone-dependent and
件下，化合物Ⅳ的收率可达到 82%。体外抗肿瘤活 hormone-independent breast cancer cell lines[J]. Chemistry-A European
Journal, 2003, 9(21): 5223-5236.
性测试表明，化合物Ⅳ对人乳腺癌细胞 MCF-7 和 [15] WANG W (王伟), YANG Y Q (杨玉琼), ZHAO J (赵军), et al. New
MDA-MB-231、人肝癌细胞 Hep G2、人宫颈癌细胞 method of reduction of acetyl ferrocene to 1-(ferrocenyl)ethanol[J].
Fine Chemical Intermediates (精细化工中间体), 2011, 41(5): 70-72.
HeLa 均有明显的抑制活性，而对人正常乳腺癌上皮 [16] CHEN W Y (陈维一), LU J (陆军), ZHANG Y W (张雅文), et al.
细胞 MCF-10A 没有毒性，其 IVTI 值高于阳性对照 Enantioselective synthesis of chiral 1-ferrocenyl alcohol via
CBS-reduction[J]. Chinese Journal of Organic Chemistry (有机化
药物 5-FU。本研究为化合物Ⅳ的合成提供了一条简 学), 2002, 22(1): 42-45.
便、易行，高收率的合成方法。同时，活性测试表 [17] TAO G D (陶贵德), FAN C L (樊陈莉), ZHANG Y Z (张玉忠).
Synthesis and electrochemical property study of acetylferrocene[J].
明化合物Ⅳ是一个抗肿瘤的先导化合物，值得进一 Research and Exploration in Laboratory (实验室研究与探索), 2007,
步研究。 26(1): 31-33.
[18] QIU X (邱潇), ZHNAG J F (张久峰), ZHAO H L (赵红莉), et al.
Synthesis of two ferrocene carboxylic acids via Willgerodt-Kindler
参考文献： reaction and mechanism[J]. Chinese Journal of Organic Chemistry
[1] BEITOLLAHI H, KHALILZADEH M A, TAJIK S, et al. Recent (有机化学), 2009, 29(5): 748-752.
advances in applications of voltammetric sensors modified with [19] LI Y (李媛), ZHNAG P (张萍), DONG Y H (董玉环), et al. The
ferrocene and its derivatives[J]. ACS Omega, 2020, 5(5): 2049-2059. reductive methods of carboxylic acids[J]. Chemistry (化学通报),
[2] SINGH A, LUMB I, MEHRA V, et al. Ferrocene-appended 2002, 65(7): 452-457.
pharmacophores: An exciting approach for modulating the biological [20] MULLER P Y, MILTON M N. The determination and interpretation
potential of organic scaffolds[J]. Dalton Transactions, 2019, 48(9): of the therapeutic index in drug development[J]. Nature Reviews
2840-2860. Drug Discovery, 2012, 11(10): 751-761.